Efficacy of Conservative Therapy of IIIА Stage Non-Small-Cell Lung Cancer
The purpose of the present research was improvement of results of treatment non-small cell lung cancer IIIА stage by using chemo- radiotherapy.The study included 164 patients with stage IIIA NSCLC. Patients were divided into four groups. The first group (32 patients) received 3D conformal radiation therapy, the second group (34 patients) - chemoradiotherapy using 3D conformal radiotherapy in combination with chemotherapy scheme GP, the third group (45 patients) - conventional radiation therapy and the fourth group (53 patient) - chemotherapy. Treatment of patients and evaluation of therapy to meet international standards. The most effective technique was chemoradiotherapy. The complete tumor regression with chemoradiotherapy occurred in 5 (14.7 ± 6.0 %) patients, partial regression - in 19 (55.9 ± 8.5 %) patients.Quality of life in patients after 3 months after chemoradiotherapy improved by 65.8 %, which contributed to the return of patients to normal activities and social disability. Side effects studied regimens do not lead to interruptions of treatment and symptomatic therapy were stopped easily.